In particular, deregulation of JAK-STAT signalling as well as overexpression of cyclin D1 by upregulated EZH2 levels have been noted to confer oncogenic potential in NKTCL [7, 14]. The gene discussed is EZH2; the disease is extranodal nasal NK/T cell lymphoma.